LIFE Atyr Pharma Inc

aTyr Pharma Inc is a biotherapeutics company, engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology.

$7.80  0.00 (0.00%)
As of 12/06/2021 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/07/2015
Outstanding shares:  27,790,677
Average volume:  251,074
Market cap:   $216,767,281
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    002120202
ISIN:        US0021202025
Valuation   (See tab for details)
PE ratio:   -9.65
PB ratio:   1.84
PS ratio:   0.00
Return on equity:   -25.67%
Net income %:   -189,197.16%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy